Each week, OHSU Research Development compiles a list of funding opportunities from internal sources, the government and private foundations. We publish the list here every Thursday. A pdf of the list is also available.
Featured Opportunities
Multidisciplinary ‖ OHSU Collaborations and Entrepreneurship and OHSU Technology Transfer IDEA Gap Funding
What: Funding for developing technologies to help bridge the early-stage funding gap often experienced by innovators when moving through the commercialization process
Who should apply: All employees and students of OHSU; if either human subjects or animals are included in the project scope of work, the applicant must meet OHSU Principal Investigator requirements and non-faculty applicants must submit written approval from their supervisor or department head authorizing effort on the grant including the specific amount
Award: Up to $40,000/typically one year
Deadline: Jan. 24, 2022
To apply, contact Jonathan Jubera to schedule a consultation to determine eligibility; further instructions in RFA
—
Cancer ‖ Kuni Foundation Imagination Grants for Cancer Research
What: Supports advanced research for the diagnosis and treatment of cancer with an emphasis on clinical applications of promising drug and technological advances, or emerging research, or a new approach that demonstrates potential for the diagnosis or treatment of cancer
How to apply: The OHSU Foundation must submit all proposals on behalf of OHSU; submit a Notice of Intent form by Jan. 26, and OHSU Foundation will provide detailed instructions on how to apply
Who should apply: Investigators at all career stages with a research interest in cancer diagnosis and treatment
Award: Up to $75,000/one year
Deadline: Notice of Intent form due: Jan. 26, 2022; Application due: Feb. 21, 2022, midnight PT
This organization is on the President’s List; submit a notice of intent form before applying
—
Cancer ‖ V Foundation Pediatric Translational and V Scholar Cancer Research Grant Program
What: Two programs to support pediatric cancer research; Translational Awards support projects that move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms and V Scholar Awards support projects either laboratory-based discovery research or translational research
Who should apply: Pediatric cancer researchers; eligibility requirements for each award are different and detailed, so see CAP listing for more details
Award: For Translational: Up to $600,000/up to three years; For V Scholar: Up to $200,000/up to two years
Deadline: Internal submission due: Jan. 26, 2022; Nomination due: Feb. 15, 2022, 2 p.m. PT
Apply through the CAP
This organization is on the President’s List; submit a notice of intent form before applying
—
Multidisciplinary ‖ OHSU Foundation Collins Medical Trust
What: Provides seed funding for projects that advance basic or clinical medical research and will be leveraged to have a greater impact in the future through being eligible for future NIH or other substantial funding; successful proposals will highlight impact on the immediate population served, Oregon, and potential national impact and preference is given to young investigators newly embarking on their research careers who are clearly supported by their respective mentors
Who should apply: Early career investigators, including postdoctoral fellows and assistant professors, who are clearly supported by their mentors
Award: Up to $30,000/one year
Deadline: Notice of Intent form is required; submission window starts Feb. 4, 2022 and goes through Feb. 11, 2022; Application due: April 29, 2022
Questions? Contact the OHSU Foundation
—
Multidisciplinary ‖ Cascadia Data Discovery Initiative and Microsoft Cascadia Azure credit award for regional collaborations in data-intensive science
What: Supports projects involving basic, clinical, and public health research; projects that involve sharing of data sets across institutions and projects that validate new computational tools or build on existing tools are encouraged, and cancer research and infectious disease research, including COVID-related proposals, are welcomed
Who should apply: Multiple PIs are required, and at least one PI must be from Fred Hutch, BC Cancer, OHSU Knight Cancer Institute, University of Washington (UW) eScience Institute, or UBC; collaborations where at least one PI is at the assistant or associate rank and between junior and senior investigators are encouraged
Award: Up to $200,000 in Azure cloud credits/From Feb. 18 to Sept. 24, 2022
Deadline: Feb. 7, 2022, 5 p.m. PT
Send questions to Katie Smolnycki
Internal Opportunities
Multidisciplinary ‖ OHSU Collaborations and Entrepreneurship and OHSU Technology Transfer IDEA Gap Funding
What: Funding for developing technologies to help bridge the early-stage funding gap often experienced by innovators when moving through the commercialization process
Who should apply: All employees and students of OHSU; if either human subjects or animals are included in the project scope of work, the applicant must meet OHSU Principal Investigator requirements and non-faculty applicants must submit written approval from their supervisor or department head authorizing effort on the grant including the specific amount
Award: Up to $40,000/typically one year
Deadline: Jan. 24, 2022
To apply, contact Jonathan Jubera to schedule a consultation to determine eligibility; further instructions in RFA
New this week!
Cancer ‖ Kuni Foundation Imagination Grants for Cancer Research
What: Supports advanced research for the diagnosis and treatment of cancer with an emphasis on clinical applications of promising drug and technological advances, or emerging research, or a new approach that demonstrates potential for the diagnosis or treatment of cancer
How to apply: The OHSU Foundation must submit all proposals on behalf of OHSU; submit a Notice of Intent form by Jan. 26, and OHSU Foundation will provide detailed instructions on how to apply
Who should apply: Investigators at all career stages with a research interest in cancer diagnosis and treatment
Award: Up to $75,000/one year
Deadline: Notice of Intent form due: Jan. 26, 2022; Application due: Feb. 21, 2022, midnight PT
This organization is on the President’s List; submit a notice of intent form before applying
Cancer ‖ OHSU Knight Cancer Institute Prostate Cancer Spore
What: Competitive renewal for KCI’s Pacific Northwest Prostate Cancer Specialized Program of Research Excellence funded by the NIH; the SPORE will likely submit four major projects and include two to four support cores, and it is anticipated that a subset of the four projects will be continuation projects and a subset will be entirely new projects
How to apply: Submissions are a one-page proposal, and the template is linked in this OHSU Now post
Who should apply: Investigators with an interest in prostate cancer research
Award: Estimated to be $200,000 per year
Deadline: Jan. 30, 2022
Contact Tom Beer, M.D., professor and deputy director of the Knight Cancer Institute, if you are thinking about submitting a proposal
New this week!
Multidisciplinary ‖ OHSU Foundation Collins Medical Trust
What: Provides seed funding for projects that advance basic or clinical medical research and will be leveraged to have a greater impact in the future through being eligible for future NIH or other substantial funding; successful proposals will highlight impact on the immediate population served, Oregon, and potential national impact and preference is given to young investigators newly embarking on their research careers who are clearly supported by their respective mentors
Who should apply: Early career investigators, including postdoctoral fellows and assistant professors, who are clearly supported by their mentors
Award: Up to $30,000/one year
Deadline: Notice of Intent form is required; submission window starts Feb. 4, 2022 and goes through Feb. 11, 2022; Application due: April 29, 2022
Questions? Contact the OHSU Foundation
New this week!
Multidisciplinary ‖ Cascadia Data Discovery Initiative and Microsoft Cascadia Azure credit award for regional collaborations in data-intensive science
What: Supports projects involving basic, clinical, and public health research; projects that involve sharing of data sets across institutions and projects that validate new computational tools or build on existing tools are encouraged, and cancer research and infectious disease research, including COVID-related proposals, are welcomed
Who should apply: Multiple PIs are required, and at least one PI must be from Fred Hutch, BC Cancer, OHSU Knight Cancer Institute, University of Washington (UW) eScience Institute, or UBC; collaborations where at least one PI is at the assistant or associate rank and between junior and senior investigators are encouraged
Award: Up to $200,000 in Azure cloud credits/From Feb. 18 to Sept. 24, 2022
Deadline: Feb. 7, 2022, 5 p.m. PT
Send questions to Katie Smolnycki
Pediatrics ‖ OHSU Doernbecher Children’s Hospital 2022 Friends of Doernbecher Grant Program
What: Supports clinical and research projects and programs at OHSU Doernbecher Children’s Hospital; pediatric-related research projects and programs that impact children’s health are supported by the program
Who should apply: OHSU and Doernbecher faculty, clinical and research staff, graduate students, medical students, fellows and postdoctoral fellows
Award: Up to $50,000/one year
Deadline: Feb. 18, 2022, 5 p.m. PT
Apply through the CAP
Cancer ‖ BRIDGE-C2 Center Small Grants Program
What: Small grants program held through the BRIDGE-C2 Center, an NCI-funded Implementation Science Center for Cancer Control, that aims to conduct rapid-cycle research aimed at eliminating longstanding gaps in cancer screening and prevention
Who should apply: Faculty, project scientists, research trainees, postdoctoral fellows and community practitioners at OHSU and OCHIN Inc.
Award: Up to $20,000/six months
Deadline: LOI due: March 1, 2022, 5 p.m. PT; Application due: June 15, 2022, 5 p.m. PT
Submit an LOI; send any questions about this opportunity to Sara McCrimmon
Multidisciplinary ‖ NIGMS, OHSU Research & Innovation and Vollum Institute OHSU Postbaccalaureate Research Education Program (PREP)
What: Program for recruiting and retaining Persons Excluded because of their Ethnicity or Race (PEER) postbacs for an intensive, mentored experience research experience with the goal to prepare them for pursuing a graduate degree in biomedical research
Who should apply: Researchers who have graduated or are in the process of graduating with a baccalaureate degree in a biomedically relevant science from an accredited college or university after June 1st, 2019, are US citizens, nationals or permanent residents, are not currently enrolled in a degree program and belong to a group considered to be underrepresented in the field of biomedical research; see more details
Award: Competitive research assistant salary and health benefits/one year
Deadline: March 1, 2022, 11:59 p.m. PT
Send questions to PREPtograd@ohsu.edu
Apply through the CAP
Multidisciplinary ‖ Alliance for Visible Diversity in Science Elevate Award
What: Recognizes a member of the Oregon Health & Science University community for making effective strides in racial equity and inclusion
Who should apply: Individuals who have catalyzed positive change in cultivating a more equitable and inclusive environment within the research community; self-nominations welcome and all OHSU members can nominate
Award: $500
Deadline: Open now
Multidisciplinary ‖ OCTRI Mobile Apps for Clinical Studies (MACS)
What: Funding to leverage new the REDCap functionality MyCap to create mobile apps that allow clinical study participants to report outcomes/data via a smartphone; the program aims to help fill the pipeline for BIP Digital Health by allowing PIs to conduct preliminary research and obtain user experience data
Who should apply: PIs who meet OHSU Principal Investigator requirements and want to create a mobile app for clinical or commercial purposes
Award: Up to $5,000/typically one year
Deadline: Rolling; application will close when funding for the fiscal year is exhausted
Submit your project intake form through REDCap
Multidisciplinary ‖ OHSU Fellowship for Diversity in Research
What: Funds researchers with the goal of increasing the diversity of the community of scholars devoted to academic scientific research at OHSU
Who should apply: Investigators with postdoctoral training experience looking to establish an independent academic research career; scholars who identify as underrepresented minorities, differently-abled and more are welcomed
Award: Up to $8,000 plus a stipend
Deadline: Applications accepted anytime
Public Health ‖ OHSU-PSU School of Public Health Kickstarter Awards
What: Funding to support pre-award activities that advance the preparation of high-quality grant or contract applications
Who should apply: OHSU and PSU faculty with primary appointment in OHSU-PSU School of Public Health who have an extramural RFA or other opportunity identified
Award: Between $500 and $5,000/up to six months
Deadline: Accepted on a rolling basis through March 31, 2022
Apply through the CAP
Multidisciplinary ‖ OHSU School of Medicine Exploratory Research Seed Grants
What: Supports investigators who need to work with an OHSU core or with the Pacific Northwest National Laboratory (PNNL) to develop preliminary data for an application for extramural research support
Who should apply: School of Medicine faculty in the professorial series who have not received this award within the last year
Award: Up to $5,000/one year
Deadline: Applications accepted anytime
Apply through the CAP
Limited Submission Opportunities
Cancer ‖ V Foundation Pediatric Translational and V Scholar Cancer Research Grant Program
What: Two programs to support pediatric cancer research; Translational Awards support projects that move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms and V Scholar Awards support projects either laboratory-based discovery research or translational research
Who should apply: Pediatric cancer researchers; eligibility requirements for each award are different and detailed, so see CAP listing for more details
Award: For Translational: Up to $600,000/up to three years; For V Scholar: Up to $200,000/up to two years
Deadline: Internal submission due: Jan. 26, 2022; Nomination due: Feb. 15, 2022, 2 p.m. PT
Apply through the CAP
This organization is on the President’s List; submit a notice of intent form before applying
Multidisciplinary ‖ Association of American Medical Colleges Herbert W. Nickens Faculty Fellowship
What: Supports junior faculty members who demonstrate leadership potential in addressing inequity in medical education and health care
Who should apply: Full-time assistant professors who have held their position from no earlier than July 1, 2019 and have received only one appointment as assistant professor
Award: $25,000/one year
Deadline: Internal submission due: Feb. 1, 2022; Application due: April 1, 2022, 8:59 p.m. PT
Apply through the CAP
Cancer ‖ Pediatric Cancer Research Foundation Research Grants
What: Supports childhood cancer research through four grants: Basic Science Research Grants, Translational Research Grants, Emerging Investigator Fellowship Grants, and Designated Grant Programs
Who should apply: Basic and Translational grant applicants must have a PhD or MD and Emerging Investigator grant applicants must have either completed two years of their fellowship or had a position as junior faculty instructor or assistant professor for up to two years from the start of the award period
Award: For Basic: Up to $750,000/up to three years; For Translational: Up to $200,000/up to two years; For Emerging Investigator: Up to $50,000/one year; For Designated: Not listed
Deadline: Internal submission due: Feb. 4, 2022; LOI due: March 1, 2022, 5 p.m. PT; Application due: June 1, 2022, 5 p.m. PT
Apply through the CAP
Aging ‖ NIA Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs) (U24 Clinical Trial Optional)
What: Coordinating Center for the Claude D. Pepper Older Americans Independence Centers program that will be a facilitator for OAIC site interactions and a conduit for translating OAIC objectives and findings to both scientific and general audiences
Who should apply: Anyone with a research interest in maintaining or restoring independence in older persons
Award: Up to $2.125 million/up to five years
Deadline: Internal submission due: Feb. 24, 2022; LOI due: April 16, 2022 (LOI not required but highly encouraged); Application due: May 16, 2022, 5 p.m. PT
Apply through the CAP
Multidisciplinary ‖ Josiah Macy Jr. Foundation Board Grants and President’s Grants
What: Supports educational projects that improve health by advancing the education and training of future health professionals through two grant mechanisms: Board Grants and President’s Grants
How to apply: When you submit your application through the CAP, you must also submit a Notice of Intent form to the OHSU Foundation; the Foundation will be pleased to provide guidance and editorial review (non-scientist, funder perspective) on your application
Who should apply: Applicants to either grant type must meet OHSU Principal Investigator requirements
Award: For Board Grants: Up to $300,000/up to three years; For President’s Grants: Up to $25,000/one year
Deadline: Internal submission due: March 1, 2022; Proposals due: Rolling
Apply through the CAP
This organization is on the President’s List; submit a notice of intent form before applying
Allergic Disease ‖ NIAID Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
What: Supports centers that integrate clinical and translational research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy and drug allergy
Who should apply: Anyone with a research interest in asthma and allergic diseases, though multiple PIs are only allowed for the Overall Program, and an investigator can serve as a PI on only one AADCRC award or application; further eligibility info in FOA
Award: Up to $4.5 million/up to five years
Deadline: Internal submission due: March 3, 2022; LOI due: May 3, 2022 (LOI not required but highly encouraged); Application due: June 3, 2022, 5 p.m. PT
Apply through the CAP
Multidisciplinary ‖ NIGMS and ORIP High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) and Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
What: Supports groups of NIH-supported investigators to purchase or upgrade a single item of high-end, specialized, commercially available instruments or integrated systems
How to apply: OHSU is not limited in the number of applications we may submit, provided that the applications are for different types of equipment; however, internal review is required. You must submit a 1-3 page preliminary proposal that names a minimum of three major users who are PIs on active NIH research grants; additional information on proposal in CAP
Who should apply: PIs do not need to have an NIH research grant or any other research support but are expected to be an expert on the requested instrument and may be a core director or tenured or non-tenured faculty member; multiple PIs are not allowed
Award: For Shared Grants: Between $50,000 and $600,000/one year; For High-End Grants: Between $600,001 and $2 million/one year
Deadline: Internal submission due: March 28, 2022; Application due: June 1, 2022, 5 p.m. PT
Apply through the CAP
Merit Prizes and Awards
Neuroscience ‖ Brain Sciences 2022 Young Investigator Awards
What: Honors three young investigators in recognition of their excellence in the field of neuroscience
Who should apply: PhDs who will be under 35 years of age by the deadline, have produced ground-breaking research and made a significant contribution to the advancement of neuroscience and are nominated by senior scientists
Award: Approximately $1,644.46 (amount converted from Swiss Francs)
Deadline: Jan. 31, 2022
Deadline extended
Multidisciplinary ‖ NOSTER and Science Microbiome Prize
What: Rewards innovative research by young investigators working on the functional attributes of the microbiota of any organism that has potential to contribute to our understanding of human or veterinary health and disease or to guide therapeutic interventions
Who should apply: Researchers younger than thirty-five who have received their degree in the last 10 years; work submitted for consideration must have been performed in the past three years
Award: $25,000
Deadline: Feb. 7, 2022
Multidisciplinary ‖ PhRMA Foundation Value Assessment Challenge Awards
What: Supports research on pressing questions related to value assessment in health care through two award mechanisms, one for health equity and one for patient-centered outcomes
Who should apply: Anyone with a research interest in health equity or patient-centered outcomes
Award: Up to $50,000
Deadline: March 1, 2022, 8:59 p.m. PT
Neuroscience ‖ Science & PINS Prize for Neuromodulation
What: Rewards innovative research that modulates neural activity through physical (electrical, magnetic, optical) stimulation of targeted sites in the nervous system with implications for translational medicine
Who should apply: Investigators younger than forty-five who have received their degree in the last 10 years; work submitted for consideration must have been performed in the past three years
Award: $25,000
Deadline: March 15, 2022
Cardiology ‖ McGill 2022 Louis and Artur Lucian Award for Research in Circulatory Diseases
What: Rewards outstanding research in the field of circulatory diseases by a scientific investigator or group of investigators whose contribution to knowledge in this field is deemed worthy of special recognition
Who should apply: Researchers whose current work is in the circulatory disease field
Award: Approximately $58,426 (amount converted from CAD)
Deadline: April 1, 2022
COVID-19 Opportunities
Due to the decline in new funding opportunities related to COVID-19, we are transitioning the separate COVID-19 Funding Alerts to this space. You can still view the archive of COVID-19 Funding Alerts, and a list of still-open opportunities will be updated weekly.
New this week!
Multidisciplinary ‖ NHLBI Notice of Information: Temporary Extension of Eligibility for NHLBI K24 Applicants Due to COVID-19
Multidisciplinary ‖ Multiple NIH Organizations Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research on Pathobiological Mechanisms of Post-Acute Sequelae of SARS-CoV-2 Infection
What: Funding to encourage investigators with expertise and insights germane to post-acute sequelae of SARS-CoV-2 infection (PASC) pathobiology to apply for supplemental funding that would enable them to leverage current awards to rapidly advance understanding of the pathobiological underpinnings of PASC
Who should apply: Grantees of active NIH awards
Award: Up to $1.5 million/up to two years
Deadline: Jan. 24, 2022, 5 p.m. PT
Multidisciplinary ‖ Multiple NIH Organizations Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
What: Supports research on strategies and interventions to address vaccine hesitancy, uptake and implementation among populations who experience health disparities in the US and its territories
Who should apply: Anyone with a research interest in vaccine hesitancy
Award: Dependent upon FOA you apply through
Deadline: Open from Feb. 5, 2022 through Jan. 8, 2023
Multidisciplinary ‖ NHLBI, NIAID and NICHD Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection
What: Supports projects that will employ existing and new clinical trial cohorts/observational cohorts to screen for co-infection, phenotype and collect biospecimens to answer COVID-19 questions outlined in the NOSI
Who should apply: Anyone with a research interest in pediatric COVID and respiratory viral co-infection
Award: Dependent upon FOA you apply through
Deadline: Open from Feb. 5, 2022 through Sept. 8, 2025
Rheumatology ‖ NIAMS Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
What: Announces to potential applicants to the NIAMS an interest in research on the impact of COVID-19 as related to diseases and conditions within the NIAMS mission
Who should apply: Anyone with a research interest in NIAMS-related topics and COVID-19
Award: Dependent upon FOA you apply through
Deadline: Open from Feb. 5, 2022 through Jan. 7, 2023
New this week!
Mental Health ‖ NIMH Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research
What: Supports research to provide an evidence base to understand how mental illness contributes to COVID-19 risk and mortality, how incident mental illness develops with COVID-19, and the development of scalable interventions to meet the public mental health needs during and resulting from the pandemic
Who should apply: Anyone with a research interest in mental illness and COVID-19
Award: Dependent upon FOA you apply through
Deadline: Open from Feb. 15, 2022 through Jan. 8, 2025
NIH Federal Opportunities
This week the NIH released funding opportunities concerning Alzheimer’s disease, dentistry and chronic health conditions. We’ve highlighted some opportunities of potential interest below.
Substance Use ‖ NIDA Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional)
What: Supports analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors and related disorders, prevention of substance use and HIV, and health service utilization
Who should apply: Anyone with a research interest in drug abuse and data analysis
Award: For R01: Not limited/up to five years; For R21: Up to $275,000/up to two years
Deadline: LOI due: Feb. 4, 2022 (LOI not required but highly encouraged); Application due: March 4, 2022, 8:59 p.m. PT
Multidisciplinary ‖ NCI, NIAMS and NIDCR Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) and (R21 Clinical Trial Optional)
What: Supports research to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research; clinical care delivery; or accessibility
Who should apply: Anyone with a research interest in bioengineering innovations and improvements
Award: Up to $275,000/up to two years
Deadline: Feb. 16, 2022, 5 p.m. PT
Aging ‖ NIA Notice of Special Interest (NOSI): Analyses of CALERIE Datasets and Biospecimens to Elucidate the Biological Effects and the Behavioral and Psychological Aspects of Sustained Caloric Restriction in Humans
What: Supports analyses of the unique research resources generated by the CALERIE (Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy) trial to improve our understanding of the effects of sustained caloric restriction in humans and its underlying mechanisms
Who should apply: Anyone with a research interest in sustained caloric restriction
Award: Dependent upon FOA you apply through
Deadline: Open from Feb. 16, 2022 through May 8, 2023
Multidisciplinary ‖ Multiple NIH Organizations Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 – Clinical Trials Optional)
What: Supports designed to study the effective adaptation, integration and implementation of recommended guidelines of care of persons with multiple chronic conditions from populations that experience health disparities
Who should apply: Anyone with a research interest in chronic conditions and health disparities
Award: Not limited/up to five years
Deadline: LOI due: Feb. 17, 2022 (LOI not required but highly encouraged); Application due: March 18, 2022, 8:59 p.m. PT
Neuroscience ‖ NIA Early and Late Stage Clinical Trials for the Spectrum of Alzheimer’s Disease/Alzheimer’s Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) and Pilot Studies for the Spectrum of Alzheimer’s Disease/Alzheimer’s Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
What: Supports either early to late stage clinical trials or early stage testing of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer’s disease and Alzheimer’s disease-related dementias
Who should apply: Anyone with a research interest in AD/ADRD and age-related cognitive decline
Award: For R01: Not limited/up to five years; For R61: Up to $650,000/up to two years
Deadline: March 4, 2022, 5 p.m. PT
Multidisciplinary ‖ Multiple NIH Organizations HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (UC2 Clinical Trial Not Allowed)
What: Supports a consortium aiming to define the innervation of the different articular and peri-articular tissues that collectively form the joint by sensory neurons that mediate the sensation of pain; see also RFA-NS-22-046
Who should apply: Anyone with a research interest in joint health and pain management
Award: Up to $8 million/up to five years
Deadline: LOI due: March 11, 2022 (LOI not required but highly encouraged); Application due: April 11, 2022, 5 p.m. PT
Biology ‖ FDA Center for Veterinary Medicine Innovative ways to provide education on antimicrobial stewardship practices in animals (U01) Clinical Trial Not Allowed
What: Supports applications to develop innovative ways to disseminate information about the health risks associated with antimicrobial resistance and the benefits of implementing good antimicrobial stewardship practices for managing diseases in food-producing animals
Who should apply: Anyone with a research interest in antimicrobial resistance
Award: Up to $1.5 million/up to five years
Deadline: LOI due: April 1, 2022 (LOI not required but highly encouraged); Application due: May 2, 2022, 8:59 p.m. PT
Administrative Supplements
Craniofacial ‖ NIDCR Notice of Special Interest (NOSI): Administrative Supplements for NIDCR Grants to Support Pain-Focused High Priority Research Areas
Other Federal Opportunities
Neuroscience ‖ DoD Autism Research Program Career Development Award
What: Supports early-career, independent investigators and the transition of established investigators from other research fields to conduct high-impact idea research and early-phase, proof-of-principle clinical trials with the potential to have a major impact on autism spectrum disorder
Who should apply: Independent investigators at or below the level of assistant professor or equivalent and established independent investigators in an area other than autism spectrum disorder at or above the level of assistant professor or equivalent and seeking to transition to a career in autism
Award: Up to $500,000/up to three years
Deadline: Not announced yet; will be posted here again when deadline is announced
Neuroscience ‖ DoD Autism Research Program Clinical Trial Award
What: Supports research with the potential to have a major impact on the treatment and management of autism spectrum disorder
Who should apply: Investigators at or above the level of assistant professor or equivalent with the option of collaborating with a young investigator who is in a current postdoctoral training position or has completed postdoctoral training and is no more than seven years from their terminal degree
Award: Up to $2.1 million/up to four years
Deadline: Not announced yet; will be posted here again when deadline is announced
Neuroscience ‖ DoD Autism Research Program Idea Development Award
What: Supports the development of innovative, high-impact ideas that advance the understanding of autism spectrum disorder and ultimately lead to improved outcomes
Who should apply: Investigators at or above the level of assistant professor or equivalent
Award: Up to $550,000/up to three years
Deadline: Not announced yet; will be posted here again when deadline is announced
Cancer ‖ DoD Lung Cancer Research Program Career Development Award
What: Supports early-career, independent researchers to conduct research under mentorship of an experienced lung cancer researcher
Who should apply: Independent investigators at the level of assistant professor, instructor or equivalent who are within five years of their first faculty appointment
Award: Up to $250,000/up to two years
Deadline: Not announced yet; will be posted here again when deadline is announced
Cancer ‖ DoD Lung Cancer Research Program Clinical Translational Research Partnership Award
What: Supports translational lung cancer studies that include an interventional clinical trial
Who should apply: Independent investigators at or above the level of assistant professor or equivalent
Award: Up to $1.2 million/up to three years
Deadline: Not announced yet; will be posted here again when deadline is announced
Cancer ‖ DoD Lung Cancer Research Program Concept Award
What: Supports highly innovative, non-incremental, high risk/potentially high-reward lung cancer research
Who should apply: Investigators at all academic levels
Award: Up to $100,000/up to one year
Deadline: Not announced yet; will be posted here again when deadline is announced
Cancer ‖ DoD Lung Cancer Research Program Idea Development Award
What: Supports early-career, independent researchers to conduct research under mentorship of an experienced lung cancer researcher
Who should apply: Independent investigators at or above the level of assistant professor or equivalent and new investigators who are within 10 years of their first faculty appointment
Award: Up to $350,000/up to two years
Deadline: Not announced yet; will be posted here again when deadline is announced
Cancer ‖ DoD Lung Cancer Research Program Investigator-Initiated Translational Research Award
What: Supports early-career, independent researchers to conduct research under mentorship of an experienced lung cancer researcher
Who should apply: Independent investigators at or above the level of assistant professor or equivalent
Award: Up to $600,000/up to three years
Deadline: Not announced yet; will be posted here again when deadline is announced
Private Opportunities
Cancer ‖ Follicular Lymphoma Foundation Curative Research to Eliminate Follicular Lymphoma Awards
What: Supports research focused on accelerating the development of cellular immunotherapy (e.g., CAR-T) and/or targeted therapy for follicular lymphoma
Who should apply: Anyone with a research interest in therapies for follicular lymphoma
Award: Up to $500,000/up to two years
Deadline: LOI due: Feb. 4, 2022, 8:59 p.m. PT; Full application due: April 15, 2022, 8:59 p.m. PT
Cancer ‖ Melanoma Research Foundation Breakthrough Consortium Pilot Translational Award
What: Supports translational research into the elucidation of biomarkers, insights into the mechanisms, and/or possible alternative treatments for immune checkpoint inhibitor resistance
Who should apply: Postdoctoral and research fellows, research associates, scientists, instructors, or professors (either assistant, associate, or full); associate or full professors must include a more junior faculty member as part of their application
Award: Up to $50,000/up to one year
Deadline: Feb. 14, 2022, 2 p.m. PT
Anesthesiology ‖ Anesthesia Patient Safety Foundation Investigator Initiated Research Grants
What: Funding for studies that will clearly improve patient safety and lead to prevention of mortality and morbidity resulting from anesthesia mishaps
Who should apply: Anyone with a research interest in anesthesia safety
Award: Up to $150,000/up to two years
Deadline: LOI due: Feb. 17, 2022, 3 p.m. PT; Full application due: August 2022
Cancer ‖ Pfizer and Lilly BRAF V600-mutant colorectal cancer: Disease education and therapy management
What: Supports educational activities related to the BRAF V600-mutant mCRC disease state that are tailored to community practices
Who should apply: Medical oncologists, pathologists, gastrointestinal surgeons, nurses, nurse navigators, and clinical trial coordinators
Award: Up to $300,000/seven months
Deadline: Feb. 18, 2022, 8:59 p.m. PT
Neuroscience ‖ Alzheimer’s Association APOE Biology in Alzheimer’s (ABA) Grant Program
What: Supports projects that aim to address some of the key challenges in Alzheimer’s research today as related to APOE contributions and biology, including but not limited to causes of the disease, experimental models of disease and early and accurate detection and diagnosis
Who should apply: Full-time faculty members with a research interest in the APOE gene
Award: Up to $300,000/up to three years
Deadline: LOI due: Feb. 24, 2022, 2 p.m. PT; Full application due: May 3, 2022, 2 p.m. PT
Rheumatology ‖ Lupus Research Alliance Lupus Innovation Award
What: Supports high-risk/high-reward approaches to major challenges in lupus research; lupus studies that explore fundamental mechanisms, novel targets and pathways, novel technologies, and interdisciplinary approaches are particularly encouraged
Who should apply: Faculty who are leading an independent research team; early career and established investigators new to lupus are encouraged to apply
Award: Up to $300,000/up to two years
Deadline: LOI due: March 1, 2022, 8:59 p.m. PT; Full application due: Aug. 1, 2022, 8:59 p.m. PT
Dermatology ‖ Milstein Medical Asian American Partnership Dermatology Research Project Award in Atopic Dermatitis
What: Supports new or ongoing clinical research projects with demonstrated potential for immediate impact on improving care for patients with atopic dermatitis in China
Who should apply: PIs must be employed by a Chinese medical institution, and co-PIs must be employed by a U.S. medical institution
Award: $60,000, with $10,000 going to the U.S. institution/up to two years
Deadline: March 1, 2022, 11:59 p.m. China time
Vascular ‖ Society for Vascular Surgery Clinical Research Seed Grant
What: Supports clinical and preferably patient-oriented research conducted with human subjects or on material of human origin such as tissues, specimens and cognitive phenomena for which an investigator directly interacts with human subjects
Who should apply: SVS active members within the first ten years of practice and fellowship- or integrated residency-trained, board-eligible, vascular surgeons within the first ten years of practice with a full-time faculty position and an SVS active member serving as a mentor
Award: Up to $25,000/up to one year
Deadline: March 1, 2022, 9:59 p.m. PT
Neuroscience ‖ Simons Foundation Autism Research Initiative (SFARI) Pilot Award
What: Provides early support for exploratory ideas, particularly those with novel hypotheses for autism and high-risk/high-reward ideas
Who should apply: Faculty with a research interest in autism; investigators new to the field of autism are encouraged to apply
Award: Up to $300,000/up to two years
Deadline: March 17, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying
Multidisciplinary ‖ Chan Zuckerberg Initiative Biohub
What: Funding to create Biohubs that aim to bring together leading scientific and technology institutions with the goal of pursuing grand scientific challenges on 10- to 15-year time horizons; this particular Biohub will focus on developing technologies to measure and observe human biology in ways that help deepen our understanding of human health and disease
Who should apply: LOIs must be submitted jointly from at least three universities and/or other research institutions within the same city or geographic area
Award: Expected to be between $200 and 250 million/up to 10 years, with possibility of additional five years
Deadline: LOI due: April 1, 2022, 5 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying
Previously Published Opportunities
Federal
January 2022
Multidisciplinary ‖ NHGRI and NIBIB New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional) LOI due: Jan. 22, 2021 (LOI not required but highly encouraged); Application due: Feb. 22, 2021, 5 p.m. PT
Neuroscience ‖ NINDS Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed) Application due: Jan. 22, 2022, 5 p.m. PT
Multidisciplinary ‖ AHRQ and CQuIPS Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18) and Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01) Deadline: R18 due: Jan. 25, 2022, 5 p.m. PT; R01 due: Feb. 5, 2022, 5 p.m. PT
Audiology ‖ NIDCD Notice of Special Interest: Expanding the Otitis Media Research Workforce: Focus on Early Stage Investigators Deadline: Open from Jan. 25, 2022 through Sept. 8, 2025
Biology ‖ NSF Dark Dimensions of the RNA Regulome (D2R2) Preliminary proposal due: Jan. 31, 2022, 5 p.m. PT; Full proposal due: Aug. 31, 2022, 5 p.m. PT
February 2022
Neuroscience ‖ NIA Cell-Specific Impact of Liquid-Liquid Phase Separation in Aging and AD/ADRD (R21 Clinical Trial Not Allowed) LOI due: Feb. 1, 2022 (LOI not required but highly encouraged); Application due: March 3, 2022, 5 p.m. PT
Environmental Health ‖ NIEHS Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional) Application due: Feb. 1, 2022, 5 p.m. PT
Pain Management ‖ Multiple NIH Organizations HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) LOI due: Feb. 2, 2022 (LOI not required but highly encouraged); Application due: March 2, 2022, 8:59 p.m. PT
Multidisciplinary ‖ Multiple NIH Organizations NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional) LOI due: Feb. 2, 2022 (LOI not required but highly encouraged); Application due: March 2, 2022, 5 p.m. PT
Substance Use ‖ Multiple NIH Organizations Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) LOI due: Feb. 3, 2022; Application due: Feb. 18, 2022, 8:59 p.m. PT
Aging ‖ NIA Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed) Deadline: Feb. 3, 2022, 5 p.m. PT
Gastroenterology ‖ NIDDK High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 – Clinical Trial Not Allowed) LOI due: Feb. 3, 2022 (LOI not required but highly encouraged); Application due: March 3, 2022, 5 p.m. PT
Endocrinology ‖ NIDDK Pilot and Feasibility Studies to Improve Technology Adoption and Reduce Health Disparities in Type 1 Diabetes Mellitus (R01 Clinical Trial Required) LOI due: Feb. 3, 2021 (LOI not required but highly encouraged); Application due: March 3, 2021, 5 p.m. PT
Endocrinology ‖ NIDDK Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes – Clinical Centers (U01 Clinical Trial Not Allowed) LOI due: Feb. 3, 2022 (LOI not required but highly encouraged); Application due: March 3, 2022, 5 p.m. PT
Genomics ‖ NHGRI Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) LOI due: Feb. 4, 2022 (LOI not required but highly encouraged); Application due: March 4, 2022, 5 p.m. PT
Neuroscience ‖ NIA and NINDS Role of Astrocytes in Degeneration of the Neurovascular Unit in AD/ADRDs (R01 Clinical Trial Not Allowed) Deadline: Feb. 4, 2022, 5 p.m. PT
Multidisciplinary ‖ Multiple NIH Organizations Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) and (R21 Clinical Trials Not Allowed) R01 due: Feb. 5, 2022, 5 p.m. PT; R21 due: Feb. 16, 2022, 5 p.m. PT
Multidisciplinary ‖ Multiple NIH Organizations Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 – Basic Experimental Studies with Humans) and (R01 Clinical Trials Not Allowed) Deadline: Clinical R01 due: Feb. 5, 2022; Basic R01 due: March 5, 2022, 5 p.m. PT
Multidisciplinary ‖ Multiple NIH Organizations Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional) Deadline: Feb. 5, 2022, 5 p.m. PT
Multidisciplinary ‖ Multiple NIH Organizations Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed) Deadline: Feb. 5, 2022, 5 p.m. PT
Multidisciplinary ‖ Multiple NIH Organizations Notice of Special Interest (NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed) Deadline: Open from Feb. 5, 2022 through Nov. 19, 2024
Multidisciplinary ‖ Multiple NIH Organizations Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional) Deadline: Feb. 5, 2022, 5 p.m. PT
Cancer ‖ NCI Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Deadline: Feb. 5, 2022, 5 p.m. PT
Cancer ‖ NCI Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) and (R21 Clinical Trial Not Allowed) Deadline: R01 due: Feb. 5, 2022, 5 p.m. PT; R21 due: Feb. 16, 2022, 5 p.m. PT
Cancer ‖ NCI Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment Deadline: Open from Feb. 5, 2022 through Oct. 9, 2024
Multidisciplinary ‖ NCI and NHLBI Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity Deadline: Open from Feb. 5, 2022 through Nov. 6, 2024
Multidisciplinary ‖ NCI, NHLBI and NICHD Notice of Special Interest (NOSI): Dietary, Physical Activity, Sedentary Behavior and Sleep Assessment Methodologies Among Infants and Young Children (Birth to 5 years) through Adults Deadline: Open from Feb. 5, 2022 through May 8, 2023
Multidisciplinary ‖ NCI, NIDCR and NIMHD Notice of Special Interest (NOSI): Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities Deadline: Open from Feb. 5, 2022 through Jan. 8, 2025
Ophthalmology ‖ NEI Regenerative Medicine Clinical Trial Planning Grant (R34 – Clinical Trials Not Allowed) Deadline: Feb. 5, 2022, 5 p.m. PT
Multidisciplinary ‖ NHLBI Notice of Special Interest (NOSI): Heart, Lung, Blood and Sleep Focused Ancillary Studies to Large Ongoing Clinical Studies (Revised) Deadline: Open from Feb. 5, 2022 through May 8, 2023
Hematology ‖ NHLBI, NIA and NIDDK Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) Deadline: Feb. 5, 2022, 5 p.m. PT
Multidisciplinary ‖ NHLBI, NIA and NINDS Notice of Special Interest (NOSI): Promoting research to understand vascular contributions to cognitive impairment and dementia (VCID) Deadline: Open from Feb. 5, 2022 through May 8, 2025
Neuroscience ‖ NIA Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional) Application due: Feb. 5, 2022, 5 p.m. PT
Neuroscience ‖ NIA and NINDS Prodromal Synaptic and Circuit Changes that Contribute to AD/ADRD Onset and Progression (R01 Clinical Trial Not Allowed) Deadline: Feb. 5, 2022, 5 p.m. PT
Infectious Disease ‖ NIAID Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine Deadline: Open from Feb. 5, 2022 through Jan. 7, 2025
Immunology ‖ NIAID Notice of Special Interest (NOSI): Molecular and Genetic Characterization of Inborn Errors of Immunity Deadline: Open from Feb. 5, 2022 through Jan. 7, 2025
Pediatrics ‖ NICHD Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 – Clinical Trial Optional), (R03 – Clinical Trial Optional) and (R21 – Clinical Trial Optional) R01 due: Feb. 5, 2022, 5 p.m. PT; R03 and R21 due: Feb. 16, 2022, 5 p.m. PT
Pediatrics ‖ NICHD Notice of Special Interest (NOSI): Advancing Innovative Non-invasive Physiologic Monitoring To Improve Fetal Assessment Deadline: Open from Feb. 5, 2022 through May 8, 2024
Multidisciplinary ‖ NIDA and NIMH Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings Deadline: Open from Feb. 5, 2022 through Jan. 8, 2025
Multidisciplinary ‖ NIMH Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) Deadline: R01 due: Feb 5, 2022; R21 due: Feb. 16, 2022, 5 p.m. PT
Neuroscience ‖ NINDS Clinical Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial Optional) Application due: Feb. 5, 2022, 5 p.m. PT
Neuroscience ‖ NINDS Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders Deadline: Open from Feb. 5, 2022 through Jan. 8, 2025
Ophthalmology ‖ NEI Ocular Surface Innervation from Cell Types to Circuit Functions (U01 Clinical Trial Not Allowed) LOI due: Feb. 7, 2022 (LOI not required but highly encouraged); Application due: March 7, 2022, 5 p.m. PT
Cancer ‖ NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) Deadline: Feb. 8, 2021, 5 p.m. PT
Infectious Disease ‖ NIAID Identification and Characterization of Persistence Mechanisms of Select Protozoan Pathogens (R01 Clinical Trial Not Allowed) Application due: Feb. 8, 2022, 5 p.m. PT
Immunology ‖ NIAID Development of Microbiome-Related Approaches for Diagnosis/Mitigation/Treatment of Radiation Injuries (U01 Clinical Trial Not Allowed) Application due: Feb. 9, 2022, 5 p.m. PT
Pharmacology ‖ FDA CDER PBPK Modeling to Support an Assessment of Bioequivalence for Locally-Acting Drugs in the Gastrointestinal Tract (U01) Clinical Trial Optional LOI due: Feb. 11, 2022 (LOI not required but highly encouraged); Application due: March 31, 2022, 8:59 p.m. PT
Multidisciplinary ‖ Multiple NIH Organizations HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required) Application due: Feb. 11, 2022, 5 p.m. PT
Neuroscience ‖ NIA and NINDS Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed) LOI due: Feb. 11, 2022 (LOI not required but highly encouraged); Application due: March 11, 2022, 5 p.m. PT
Multidisciplinary ‖ NIBIB and NIMHD Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) Deadline: Feb. 11, 2022, 5 p.m. PT
Multidisciplinary ‖ AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Research Scientist Career Development Award (K01) Deadline: Feb. 12, 2022, 5 p.m. PT
Aging ‖ NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed) Deadline: Feb. 12, 2022, 5 p.m. PT
Neuroscience ‖ Multiple NIH Organizations BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) Application due: Feb. 15, 2022, 5 p.m. PT
Pain Management ‖ NCCIH NIH-DOD-VA Pain Management Collaboratory – Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required) LOI due: Feb. 15, 2022 (LOI not required but highly encouraged); Application due: March 15, 2022, 5 p.m. PT
Cardiology ‖ NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) and Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) Application due: Feb. 15, 2022, 5 p.m. PT
Multidisciplinary ‖ NIA and NIMH Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) LOI due: Feb. 15, 2022 (LOI not required but highly encouraged); Application due: March 15, 2022, 5 p.m. PT
Multidisciplinary ‖ NIDA High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) Application due: Feb. 15, 2022, 5 p.m. PT
Cancer ‖ NCI Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology Deadline: Open from Feb. 16, 2022 through May 8, 2023
Immunology ‖ NIAID Notice of Special Interest (NOSI): Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity Deadline: Open from Feb. 16, 2022 through Jan. 7, 2025
Neuroscience ‖ Multiple NIH Organizations Notice of Special Interest (NOSI): BRAIN Initiative: Translation of Groundbreaking Technologies from Early-stage Development through Early Clinical Study via Blueprint MedTech Deadline: Open from Feb. 18, 2022 through June 20, 2024
Infectious Disease ‖ NIAID Advancing Group A Streptococcus Vaccine Discovery (R01 Clinical Trial Not Allowed) Application due: Feb. 18, 2022, 5 p.m. PT
Mental Health ‖ NIMH Enhanced Interpersonal Focused Strategies for Suicide Prevention Interventions (R34 Clinical Trial Required) Application due: Feb. 18, 2022, 5 p.m. PT
Endocrinology ‖ NIDDK Analysis, Technology, Leadership, Administration and Science (ATLAS) Center (U24 Clinical Trial Not Allowed) LOI due: Feb. 24, 2022 (LOI not required but highly encouraged); Application due: March 24, 2022, 5 p.m. PT
Pediatrics ‖ NICHD Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional) LOI due: Feb. 28, 2022 (LOI not required but highly encouraged); Application due: March 30, 2022, 5 p.m. PT
Multidisciplinary ‖ NICHD, NIDA and NIMH Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional) and Scientific Leadership Center (UM2 Clinical Trial Optional) LOI due: Feb. 28, 2022 (LOI not required but highly encouraged); Application due: March 31, 2022, 5 p.m. PT
Multidisciplinary ‖ NICHD and ORWH Promoting Reproductive Health for Adolescents and Adults with Disabilities (R01 Clinical Trial Optional) LOI due: Feb. 28, 2022 (LOI not required but highly encouraged); Application due: March 30, 2022, 5 p.m. PT
March 2022
Biology ‖ FDA Research to support the development of alternatives to antimicrobials for use in food-producing animals (U01) Clinical Trial Not Allowed LOI due: March 1, 2022 (LOI not required but highly encouraged); Application due: April 1, 2022, 8:59 p.m. PT
Neuroscience ‖ NIH Common Fund SPARC VNS Endpoints from Standardized Parameters (VESPA) (U54 Clinical Trial Required) LOI due: March 1, 2022 (LOI not required but highly encouraged); Application due: April 1, 2022, 5 p.m. PT
Substance Use ‖ Multiple NIH Organizations HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed) Deadline: March 10, 2022, 5 p.m. PT
Neuroscience ‖ NIA Notice of Special Interest (NOSI): Novel Approaches to Diagnosing and Studying Clinical Alzheimer’s Disease and Related Dementias Deadline: Open from March 11, 2022 through Nov. 13, 2024
Neuroscience ‖ NIA and NINDS Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) Deadline: March 11, 2022, 5 p.m. PT
Multidisciplinary ‖ NCI and ODP Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Not Allowed) LOI due: March 20, 2022 (LOI not required but highly encouraged); Application due: May 8, 2022, 5 p.m. PT
Cancer ‖ NCI Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) and Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) LOI due: March 22, 2022 (LOI not required but highly encouraged); Application due: April 22, 2022, 5 p.m. PT
Cancer ‖ NCI Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) LOI due: March 22, 2021 (LOI not required but highly encouraged); Application due: April 22, 2022, 5 p.m. PT
April 2022
HIV/AIDS ‖ NIDA, NIMH and OBSSR Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) LOI due: April 10, 2022 (LOI not required but highly encouraged); Application due: May 10, 2022, 5 p.m. PT
Aging ‖ NIA Pharmacokinetic and Pharmacodynamic (PK/PD) Studies of mTOR Inhibitors on Aging-Related Indications (U01 Clinical Trial Required) LOI due: April 14, 2022 (LOI not required but highly encouraged); Application due: June 15, 2022, 5 p.m. PT
Multidisciplinary ‖ Multiple NIH Organizations Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) and Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) Application due: April 18, 2022, 5 p.m. PT
Immunology ‖ NIAID Host Immunity and Novel Immunization Strategies for Clostridioides difficile Infection (CDI) (U19 Clinical Trial Not Allowed) LOI due: April 20, 2022 (LOI not required but highly encouraged); Application due: May 20, 2022, 5 p.m. PT
Multidisciplinary ‖ NIDDK High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) LOI due: April 20, 2022 (six weeks before application deadline) (LOI not required but highly encouraged); Application due: June 1, 2022, 5 p.m. PT
May 2022
Cancer ‖ NCI Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) LOI due: May 7, 2022 (LOI not required but highly encouraged); Application due: June 7, 2022, 5 p.m. PT
Multidisciplinary ‖ NHLBI Notice of Special Interest (NOSI): Examining Effects of HIV Pre-Exposure Prophylaxis (PrEP) on Heart, Lung, Blood, and Sleep Function Deadline: Open from May 7, 2022 through May 8, 2025
Multidisciplinary ‖ NIGMS National and Regional Resources (R24 – Clinical Trial Not Allowed) LOI due: May 14, 2022 (LOI not required but highly encouraged); Application due: June 14, 2022, 5 p.m. PT
Mental Health ‖ NIMH Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional) LOI due: May 20, 2022 (LOI not required but highly encouraged); Application due: June 21, 2022, 5 p.m. PT
June 2022
Multidisciplinary ‖ Multiple NIH Organizations Risk and Protective Factors of Family Health and Family Level Interventions (R01 – Clinical Trial Optional) Deadline: June 5, 2022, 5 p.m. PT
Substance Use ‖ NIAAA Notice of Special Interest (NOSI): Epidemiology and Prevention of Alcohol Misuse in Understudied Young Adult Populations; Military, Workforce, and Community College Deadline: Open from June 5, 2022 through Sept. 8, 2025
Multidisciplinary ‖ Multiple NIH Organizations Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required), (R01 Clinical Trial Required) and (R01 Clinical Trials Not Allowed) Deadline: June 21, 2022, 5 p.m. PT
Open
Neuroscience ‖ DoD Amyotrophic Lateral Sclerosis Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced
Cancer ‖ DoD Breast Cancer Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced
Neuroscience ‖ DoD Epilepsy Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced
Cancer ‖ DoD Ovarian Cancer Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced
Multidisciplinary ‖ DoD Tuberous Sclerosis Complex Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced
Substance Abuse ‖ NIAAA NOSI: Advances in Research for the Treatment, Services, and Recovery of Alcohol Use Disorder Deadline: Open through Sept. 8, 2023
HIV/AIDS ‖ NIMH Notice of Special Interest: Advancing Health Communication Research on HIV Prevention, Treatment and Cure Deadline: Open through March 1, 2024
Multidisciplinary ‖ NHLBI and NIEHS NOSI: Stimulating Intervention Research to Reduce Cardiopulmonary Impacts of Particulate Matter in Air Pollution among High-Risk Populations Deadline: Open through Sept. 7, 2025
Genomics ‖ NHGRI Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed) Applications are accepted by continuous receipt
Biology ‖ NSF Biophotonics Applications accepted anytime
Biology ‖ NSF Cellular and Biochemical Engineering Applications accepted anytime
Biology ‖ NSF Dear Colleague Letter: Conferences for Building Computational Literacy in Biological Sciences Deadline: Open
Multidisciplinary ‖ NSF Dear Colleague Letter: Pilot Projects for Cyberinfrastructure Centers of Excellence Deadline: Rolling
Biology ‖ NSF Division of Integrative Organismal Systems Core Programs Applications accepted anytime
Biology ‖ NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB) Deadline: Open
Multidisciplinary ‖ NSF Enabling Discovery through GEnomic Tools (EDGE) Deadline: Open
Biology ‖ NSF Infrastructure Innovation for Biological Research (Innovation) Deadline: Open
Biology ‖ NSF Transitions to Excellence in Molecular and Cellular Biosciences Research (Transitions) Deadline: Open
Private
January 2022
Dermatology ‖ National Psoriasis Foundation Psoriatic Disease Research Fellowships Deadline: Jan. 21, 2022, 5 p.m. PT
Dermatology ‖ National Psoriasis Foundation Research Funding Deadline: Jan. 21, 2022, 5 p.m. PT
Pediatrics ‖ American Academy of Pediatrics CATCH Planning, Implementation, and Resident Grants Deadline: Jan. 24, 2022, 9:59 p.m. PT
Dermatology ‖ Pfizer 2022 Fellowship for Inflammatory Dermatological Diseases Deadline: Jan. 24, 2022, 8:59 p.m. PT
Gastroenterology ‖ Pfizer 2022 Inflammatory Bowel Disease (IBD) Fellowship Deadline: Jan. 27, 2022, 8:59 p.m. PT
Multidisciplinary ‖ L’Oréal USA For Women in Science Fellowship Deadline: Jan. 28, 2022, 8:59 p.m. PT
Neuroscience ‖ Parkinson’s Foundation Community Grants Deadline: Jan. 28, 2022, 8:59 p.m. PT
Multidisciplinary ‖ American Psychological Foundation Alice F. Chang Cancer Wellness Grant Deadline: Jan. 31, 2022
Psychology ‖ American Psychological Foundation Div. 37 Diane J. Willis Early Career Award Deadline: Jan. 31, 2022
Cancer ‖ EvansMDS Discovery Research Grants LOI due: Jan. 31, 2022; Full application due: April 2022
This organization is on the President’s List; submit a notice of intent form before applying
Cancer ‖ EvansMDS Young Investigator Awards Deadline: Jan. 31, 2022
This organization is on the President’s List; submit a notice of intent form before applying
February 2022
Neuroscience ‖ FRAXA Research Foundation Clinical Trial Grants Deadline: Feb. 1, 2022, 8:59 p.m. PT
Neuroscience ‖ FRAXA Research Foundation Fellowships Deadline: Feb. 1, 2022, 8:59 p.m. PT
Cancer ‖ Jane Coffin Childs Memorial Fund for Medical Research Postdoctoral Fellowship Deadline: Feb. 1, 2022
Physical Therapy ‖ Massage Therapy Foundation Research Support Grant Deadline: Feb. 1, 2022, 9:59 p.m. PT
Multidisciplinary ‖ Patient-Centered Outcomes Research Institute Implementation Funding LOI due: Feb. 1, 2022, 2 p.m. PT; Full application due: April 12, 2022, 2 p.m. PT
Multidisciplinary ‖ PhRMA Foundation Health Outcomes Research and Translational Medicine Grants Deadline: Feb. 1, 2022, 8:59 p.m. PT
Cancer ‖ Sarcoma Foundation of America 2022 Research Grants Deadline: Feb. 1, 2022, 2 p.m. PT
Nursing ‖ National League for Nursing Nursing Education Research Grants Deadline: Feb. 3, 2022
Neuroscience ‖ Alzheimer’s Drug Discovery Foundation Core Funding Programs LOI due: Feb. 4, 2022, 2 p.m. PT; Applications due: April 8, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying
Emergency Medicine ‖ Emergency Medicine Foundation Health Disparities Research Grant Deadline: Feb. 4, 2022
Emergency Medicine ‖ Emergency Medicine Foundation and Society for Academic Emergency Medicine Medical Student Research Grant Deadline: Feb. 4, 2022
Nursing ‖ Johnson & Johnson Innovation Nurse-led Tech QuickFire Challenge Deadline: Feb. 4, 2022
Cancer ‖ Leukemia Research Foundation Hollis Brownstein Research Grants Program LOI due: Feb. 4, 2022, 10 a.m. PT; Applications due: April 4, 2022, 10 a.m. PT
Neuroscience ‖ Parkinson’s Foundation Movement Disorders Fellowship Deadline: Feb. 4, 2022
Multidisciplinary ‖ Southwest National Primate Research Center Pilot Research Grants LOI due: Feb. 4, 2022; Full proposal due: March 25, 2022
Neuroscience ‖ Organization for Autism Research Graduate Research Grant Competition Deadline: Feb. 7, 2022, 8:59 p.m. PT
Gastroenterology ‖ Pfizer 2022 IBD Competitive Grant Program Deadline: Feb. 7, 2022, 8:59 p.m. PT
Surgery ‖ American Shoulder and Elbow Surgeons Foundation Research Grant Deadline: Feb. 8, 2022
Multidisciplinary ‖ Patient-Centered Outcomes Research Institute Research Funding LOI due: Feb. 8, 2022, 2 p.m. PT; Full application due: May 3, 2022, 2 p.m. PT
Rheumatology ‖ Pfizer 2022 Rheumatology Competitive Grant Program Deadline: Feb. 8, 2022, 8:59 p.m. PT
Cancer ‖ American Society for Radiation Oncology Minority Summer Fellowship Award Deadline: Feb. 11, 2022
Multidisciplinary ‖ Danone North America Gut Microbiome, Yogurt and Probiotics Fellowship Grant Deadline: Feb. 14, 2022
Nephrology ‖ National Kidney Foundation Young Investigator Research Grant Deadline: Feb. 14, 2022
Psychology ‖ American Psychological Foundation Dr. Christine Blasey-Ford Grant Deadline: Feb. 15, 2022
Psychology ‖ American Psychological Foundation Trauma Psychology Grant Deadline: Feb. 15, 2022
Rheumatology ‖ Pfizer 2022 Rheumatology Fellowship Deadline: Feb. 15, 2022, 8:59 p.m. PT
Cardiology ‖ American Heart Association Research Grants Deadline: Deadlines go through Feb. 16, 2022, 1 p.m. PT
Pulmonology ‖ Cystic Fibrosis Foundation Funding Opportunities Deadline: All applications due Feb. 16, 2022, 2 p.m. PT, except First and Second Year Fellowships, due March 2, 2022, 2 p.m. PT
Neuroscience ‖ National Multiple Sclerosis Society Therapeutic Development Opportunities Addressing Nervous System Repair in Multiple Sclerosis LOI due: Feb. 16, 2022; Full proposal due: Feb. 23, 2022
Neuroscience ‖ New York Stem Cell Foundation NYSCF – Robertson Neuroscience Investigator Awards Deadline: Feb. 16, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying
Allergies ‖ Johnson & Johnson Innovation Food Allergy Prevention QuickFire Challenge Deadline: Feb. 18, 2022
Cancer ‖ Alex’s Lemonade Stand Foundation Pediatric Oncology Student Training Program Deadline: Feb. 21, 2022, 5 p.m. PT
Multidisciplinary ‖ Human Animal Bond Research Institute Addressing Evidence-Based Health Benefits of Human-Animal Interaction Deadline: Feb. 24, 2022, 8:59 p.m. PT
Dermatology ‖ Pfizer Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Early Career Investigators Deadline: Feb. 24, 2022, 8:59 p.m. PT
Audiology ‖ Hearing Health Foundation Emerging Research Grants Deadline: Feb. 25, 2022
Sexual Health ‖ Sexual Medicine Society of North America Young Clinicians Research Grant Deadline: Feb. 28, 2022
Neuroscience ‖ Simons Foundation Autism Research Initiative Bridge to Independence Award Deadline: Feb. 28, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying
March 2022
Cardiology ‖ Abbott Fellowship Program Grants Deadline: March 1, 2021
Cancer ‖ Mark Foundation Endeavor Awards Deadline: LOI due: March 1, 2022; LOI due: Aug. 2, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying
Physical Therapy ‖ Massage Therapy Foundation Research Award LOI due: March 1, 2022, 9:59 p.m. PT; Full application due: Aug. 1, 2022, 9:59 p.m. PT
Hematology ‖ Pfizer 2022 Global Hemophilia ASPIRE Deadline: March 1, 2022, 8:59 p.m. PT
Multidisciplinary ‖ Robert Wood Johnson Foundation Health Policy Research Scholars Deadline: March 16, 2022, noon PT
This organization is on the President’s List; submit a notice of intent form before applying
April 2022
Neuroscience ‖ James S. McDonnell Foundation Opportunity Awards Deadline: April 1, 2022, 1:59 p.m. PT
Open
HIV/AIDS ‖ amfAR Target Grants Deadline: Rolling
Substance Abuse ‖ Charles Koch Foundation Substance Abuse Research Grants Deadline: Rolling
Neuroscience ‖ Cure SMA Newborn Screening for Spinal Muscular Atrophy Program Deadline: Rolling
Pulmonology ‖ Cystic Fibrosis Foundation Path to a Cure: Industry Award Program Deadline: Rolling, but LOI required
Multidisciplinary ‖ Robert Wood Johnson Foundation Evidence for Action: Innovative Research to Advance Racial Equity Deadline: Rolling; applicant webinar on Oct. 13, 2021, 10 a.m. PT
This organization is on the President’s List; submit a notice of intent form before applying
Multidisciplinary ‖ Robert Wood Johnson Foundation Evidence for Action: Investigator-Initiated Research to Build a Culture of Health Deadline: Open
This organization is on the President’s List; submit a notice of intent form before applying
Multidisciplinary ‖ Robert Wood Johnson Foundation Pioneering Ideas: Exploring the Future to Build a Culture of Health Deadline: Rolling
This organization is on the President’s List; submit a notice of intent form before applying
Neuroscience ‖ SFARI Supplement to Enhance Equity and Diversity (SEED) Deadline: Rolling
This organization is on the President’s List; submit a notice of intent form before applying
